Psychiatry · Aguadilla, PR
NPI
1306817911
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
St # 2 Km. 118.9 Bo. Ceibabaja, Aguadilla , Puerto Rico
Aguadilla, PR, 00603
Phone (787) 882-0570
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$159K
9,808 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Miljan I Rosado Santiago prescribed most often to Medicare patients was Clonazepam, with 1,356 prescriptions and refills. In total Miljan I Rosado Santiago wrote 9,808 Medicare prescriptions that cost $159K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clonazepam Generic | 1,356 | 1,358 | 145 | $16K |
| Buspirone Hcl Generic | 1,164 | 1,168 | 139 | $18K |
| Risperidone Generic | 900 | 912 | 81 | $4,889 |
| Amitriptyline Hcl Generic | 731 | 736 | 82 | $12K |
| Fluoxetine Hcl Generic | 686 | 693 | 88 | $6,468 |
| Temazepam Generic | 590 | 590 | 70 | $4,623 |
| Quetiapine Fumarate Generic | 466 | 474 | 47 | $3,740 |
| Alprazolam Generic | 454 | 454 | 52 | $4,099 |
| Citalopram Hbr Citalopram Hydrobromide | 380 | 388 | 50 | $2,059 |
| Bupropion Hcl Sr Bupropion Hcl | 358 | 371 | 46 | $3,116 |
| Bupropion Xl Bupropion Hcl | 310 | 315 | 33 | $7,460 |
| Fluphenazine Hcl Generic | 267 | 267 | 23 | $18K |
| Paroxetine Hcl Generic | 255 | 258 | 27 | $1,782 |
| Trifluoperazine Hcl Generic | 204 | 206 | 26 | $8,733 |
| Lorazepam Generic | 190 | 190 | 25 | $1,588 |
Brand drugs: 89 claims; generic drugs: 9,719 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Miljan I Rosado Santiago were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.